As of 12:59pm ET
| -0.03 / -1.71%|
The 3 analysts offering 12-month price forecasts for CytRx Corp have a median target of 8.00, with a high estimate of 10.00 and a low estimate of 3.00. The median estimate represents a +365.12% increase from the last price of 1.72.
The current consensus among 3 polled investment analysts is to Buy stock in CytRx Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.